0 XP   0   0   0

Mangalam Drugs & Organics Limited
Buy, Hold or Sell?

Should you buy, hold or sell Mangalam Drugs & Organics Limited?

I guess you are interested in Mangalam Drugs & Organics Limited. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

Let's analyse Mangalam Drugs & Organics Limited

Let's start. I'm going to help you getting a better view of Mangalam Drugs & Organics Limited. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

  1. Company's Financial Health
    A deep dive into the books. How are the numbers doing? Is Mangalam Drugs & Organics Limited even making a profit? Is the company skyrocketing? Or is it sinking like the Titanic. The trend is your friend.
  2. Market Valuation
    Finally, you now have an insight of how Mangalam Drugs & Organics Limited is doing in the market. If the company is worth buying. The latest step is to find out how other investors value Mangalam Drugs & Organics Limited. The closing price on 2023-01-27 was INR114.15 per share. Is the company over- or underpriced?
  3. Key Performance Indicators
    A total overlook on how the company is doing. Based on the (trends in) the key performance indicators.
Mangalam Drugs & Organics Limited Daily Candlestick Chart
Mangalam Drugs & Organics Limited Daily Candlestick Chart
Summary









1. Valuation of Mangalam Drugs & Organics Limited




Current price per share

INR114.15

2. Growth of Mangalam Drugs & Organics Limited




Is Mangalam Drugs & Organics Limited growing?

Current yearPrevious yearGrowGrow %
How rich?$18.5m$16m$2.4m13.1%

How much money is Mangalam Drugs & Organics Limited making?

Current yearPrevious yearGrowGrow %
Making money$2.4m$3.4m-$1m-42.3%
Net Profit Margin4.4%7.4%--

How much money comes from the company's main activities?

3. Financial Health of Mangalam Drugs & Organics Limited




Comparing to competitors in the Drugs - Generic industry




  Industry Rankings (Drugs - Generic)  



Summary

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is efficient in making profit.
Using its investors money, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is able to pay all its debts with equity.

1.1. Profitability of Mangalam Drugs & Organics Limited.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Mangalam Drugs & Organics Limited earns for each ₹1 of revenue.

  • Above 10% is considered healthy but always compare Mangalam Drugs & Organics Limited to the Drugs - Generic industry mean.
  • A Net Profit Margin of 4.4% means that ₹0.04 for each ₹1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Mangalam Drugs & Organics Limited:

  • The MRQ is 4.4%. The company is making a profit. +1
  • The TTM is 4.4%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ4.4%TTM4.4%0.0%
TTM4.4%YOY7.4%-3.0%
TTM4.4%5Y3.6%+0.7%
5Y3.6%10Y3.5%+0.2%
Compared to industry (Drugs - Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ4.4%9.9%-5.5%
TTM4.4%10.3%-5.9%
YOY7.4%8.0%-0.6%
5Y3.6%6.3%-2.7%
10Y3.5%6.4%-2.9%
1.1.2. Return on Assets

Shows how efficient Mangalam Drugs & Organics Limited is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Mangalam Drugs & Organics Limited to the Drugs - Generic industry mean.
  • 6.0% Return on Assets means that Mangalam Drugs & Organics Limited generated ₹0.06 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Mangalam Drugs & Organics Limited:

  • The MRQ is 6.0%. Using its assets, the company is efficient in making profit. +1
  • The TTM is 6.0%. Using its assets, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ6.0%TTM6.0%0.0%
TTM6.0%YOY10.6%-4.6%
TTM6.0%5Y5.0%+1.0%
5Y5.0%10Y5.3%-0.3%
Compared to industry (Drugs - Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ6.0%2.7%+3.3%
TTM6.0%2.8%+3.2%
YOY10.6%2.6%+8.0%
5Y5.0%2.0%+3.0%
10Y5.3%2.0%+3.3%
1.1.3. Return on Equity

Shows how efficient Mangalam Drugs & Organics Limited is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Mangalam Drugs & Organics Limited to the Drugs - Generic industry mean.
  • 13.1% Return on Equity means Mangalam Drugs & Organics Limited generated ₹0.13 for each ₹1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Mangalam Drugs & Organics Limited:

  • The MRQ is 13.1%. Using its investors money, the company is less efficient in making profit.
  • The TTM is 13.1%. Using its investors money, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ13.1%TTM13.1%0.0%
TTM13.1%YOY21.4%-8.3%
TTM13.1%5Y10.6%+2.4%
5Y10.6%10Y12.6%-1.9%
Compared to industry (Drugs - Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ13.1%4.5%+8.6%
TTM13.1%4.7%+8.4%
YOY21.4%5.3%+16.1%
5Y10.6%4.3%+6.3%
10Y12.6%5.0%+7.6%

1.2. Operating Efficiency of Mangalam Drugs & Organics Limited.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Mangalam Drugs & Organics Limited is operating .

  • Measures how much profit Mangalam Drugs & Organics Limited makes for each ₹1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Mangalam Drugs & Organics Limited to the Drugs - Generic industry mean.
  • An Operating Margin of 0.0% means the company generated ₹0.00  for each ₹1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Mangalam Drugs & Organics Limited:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y5.4%-5.4%
5Y5.4%10Y7.2%-1.9%
1.2.2. Operating Ratio

Measures how efficient Mangalam Drugs & Organics Limited is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drugs - Generic industry mean).
  • An Operation Ratio of 0.74 means that the operating costs are ₹0.74 for each ₹1 in net sales.

Let's take a look of the Operating Ratio trends of Mangalam Drugs & Organics Limited:

  • The MRQ is 0.741. The company is efficient in keeping operating costs low. +1
  • The TTM is 0.741. The company is efficient in keeping operating costs low. +1
Trends
Current periodCompared to+/- 
MRQ0.741TTM0.7410.000
TTM0.741YOY0.662+0.078
TTM0.7415Y1.223-0.482
5Y1.22310Y1.394-0.172
Compared to industry (Drugs - Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7410.441+0.300
TTM0.7410.490+0.251
YOY0.6620.653+0.009
5Y1.2231.000+0.223
10Y1.3941.083+0.311

1.3. Liquidity of Mangalam Drugs & Organics Limited.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Mangalam Drugs & Organics Limited is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drugs - Generic industry mean).
  • A Current Ratio of 1.40 means the company has ₹1.40 in assets for each ₹1 in short-term debts.

Let's take a look of the Current Ratio trends of Mangalam Drugs & Organics Limited:

  • The MRQ is 1.402. The company is just able to pay all its short-term debts.
  • The TTM is 1.402. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.402TTM1.4020.000
TTM1.402YOY1.228+0.175
TTM1.4025Y1.221+0.181
5Y1.22110Y1.226-0.005
Compared to industry (Drugs - Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ1.4021.715-0.313
TTM1.4021.635-0.233
YOY1.2281.431-0.203
5Y1.2211.014+0.207
10Y1.2260.886+0.340
1.3.2. Quick Ratio

Measures if Mangalam Drugs & Organics Limited is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Mangalam Drugs & Organics Limited to the Drugs - Generic industry mean.
  • A Quick Ratio of 0.37 means the company can pay off ₹0.37 for each ₹1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Mangalam Drugs & Organics Limited:

  • The MRQ is 0.372. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.372. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.372TTM0.3720.000
TTM0.372YOY0.503-0.131
TTM0.3725Y0.388-0.016
5Y0.38810Y0.423-0.035
Compared to industry (Drugs - Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3720.860-0.488
TTM0.3720.811-0.439
YOY0.5030.629-0.126
5Y0.3880.498-0.110
10Y0.4230.440-0.017

1.4. Solvency of Mangalam Drugs & Organics Limited.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Mangalam Drugs & Organics Limited assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Mangalam Drugs & Organics Limited to Drugs - Generic industry mean.
  • A Debt to Asset Ratio of 0.54 means that Mangalam Drugs & Organics Limited assets are financed with 54.2% credit (debt) and the remaining percentage (100% - 54.2%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Mangalam Drugs & Organics Limited:

  • The MRQ is 0.542. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.542. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.542TTM0.5420.000
TTM0.542YOY0.505+0.037
TTM0.5425Y0.537+0.004
5Y0.53710Y0.610-0.073
Compared to industry (Drugs - Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5420.484+0.058
TTM0.5420.519+0.023
YOY0.5050.513-0.008
5Y0.5370.543-0.006
10Y0.6100.499+0.111
1.4.2. Debt to Equity Ratio

Measures if Mangalam Drugs & Organics Limited is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Mangalam Drugs & Organics Limited to the Drugs - Generic industry mean.
  • A Debt to Equity ratio of 118.1% means that company has ₹1.18 debt for each ₹1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Mangalam Drugs & Organics Limited:

  • The MRQ is 1.181. The company is able to pay all its debts with equity. +1
  • The TTM is 1.181. The company is able to pay all its debts with equity. +1
Trends
Current periodCompared to+/- 
MRQ1.181TTM1.1810.000
TTM1.181YOY1.019+0.162
TTM1.1815Y1.163+0.018
5Y1.16310Y1.979-0.816
Compared to industry (Drugs - Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ1.1810.937+0.244
TTM1.1811.090+0.091
YOY1.0191.056-0.037
5Y1.1631.194-0.031
10Y1.9791.098+0.881

2. Market Valuation of Mangalam Drugs & Organics Limited

2. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₹1 in earnings Mangalam Drugs & Organics Limited generates.

  • Above 15 is considered overpriced but always compare Mangalam Drugs & Organics Limited to the Drugs - Generic industry mean.
  • A PE ratio of 8.28 means the investor is paying ₹8.28 for every ₹1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Mangalam Drugs & Organics Limited:

  • The EOD is 9.191. Very good. +2
  • The MRQ is 8.281. Very good. +2
  • The TTM is 8.281. Very good. +2
Trends
Current periodCompared to+/- 
EOD9.191MRQ8.281+0.910
MRQ8.281TTM8.2810.000
TTM8.281YOY5.625+2.657
TTM8.2815Y4.352+3.929
5Y4.35210Y6.826-2.473
Compared to industry (Drugs - Generic)
PeriodCompanyIndustry (mean)+/- 
EOD9.19177.207-68.016
MRQ8.28185.784-77.503
TTM8.28192.482-84.201
YOY5.62545.908-40.283
5Y4.35269.511-65.159
10Y6.82686.803-79.977
2.2. Price Earnings to Growth Ratio

Measures the predicted future growth of Mangalam Drugs & Organics Limited.

  • Lower is better.
  • A PEG ratio of 1 means the market price of the stock and the expected future earnings are on par.

Let's take a look of the Price Earnings to Growth Ratio trends of Mangalam Drugs & Organics Limited:

  • The MRQ is 11.784. Seems overpriced? -1
  • The TTM is 11.784. Seems overpriced? -1
Trends
Current periodCompared to+/- 
MRQ11.784TTM11.7840.000
TTM11.784YOY1.660+10.124
TTM11.7845Y11.348+0.436
5Y11.34810Y9.426+1.922
Compared to industry (Drugs - Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ11.784-7.855+19.639
TTM11.7840.877+10.907
YOY1.6600.085+1.575
5Y11.348-0.157+11.505
10Y9.4260.358+9.068

2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Mangalam Drugs & Organics Limited is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Drugs - Generic industry mean).
  • A PB ratio of 1.08 means the investor is paying ₹1.08 for each ₹1 in book value.

Let's take a look of the Price to Book Ratio trends of Mangalam Drugs & Organics Limited:

  • The EOD is 1.200. Good. +1
  • The MRQ is 1.081. Good. +1
  • The TTM is 1.081. Good. +1
Trends
Current periodCompared to+/- 
EOD1.200MRQ1.081+0.119
MRQ1.081TTM1.0810.000
TTM1.081YOY1.203-0.122
TTM1.0815Y1.226-0.145
5Y1.22610Y1.897-0.671
Compared to industry (Drugs - Generic)
PeriodCompanyIndustry (mean)+/- 
EOD1.2003.452-2.252
MRQ1.0813.836-2.755
TTM1.0814.390-3.309
YOY1.2033.369-2.166
5Y1.2263.239-2.013
10Y1.8972.355-0.458
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Mangalam Drugs & Organics Limited compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--12.49412.4940%16.962-26%8.193+52%10.569+18%
Book Value Growth--1.1511.1510%1.258-9%1.126+2%1.298-11%
Book Value Per Share--95.12295.1220%82.628+15%73.883+29%55.073+73%
Book Value Per Share Growth--1.1511.1510%1.258-9%1.126+2%1.298-11%
Current Ratio--1.4021.4020%1.228+14%1.221+15%1.226+14%
Debt To Asset Ratio--0.5420.5420%0.505+7%0.537+1%0.610-11%
Debt To Equity Ratio--1.1811.1810%1.019+16%1.163+2%1.979-40%
Dividend Per Share----0%-0%0.099-100%0.055-100%
Eps--12.41912.4190%17.672-30%8.559+45%7.662+62%
Eps Growth--0.7030.7030%3.389-79%1.522-54%1.954-64%
Free Cash Flow Per Share---1.238-1.2380%-2.455+98%4.891-125%4.775-126%
Free Cash Flow Per Share Growth--1.4961.4960%-0.165+111%1.461+2%1.328+13%
Free Cash Flow To Equity Per Share--0.6440.6440%-0.751+217%0.082+683%0.062+932%
Free Cash Flow To Equity Per Share Growth--2.8582.8580%-8.717+405%-0.900+131%2.909-2%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--8.867--------
Intrinsic Value_10Y_min--6.903--------
Intrinsic Value_1Y_max---0.781--------
Intrinsic Value_1Y_min---0.759--------
Intrinsic Value_3Y_max---1.075--------
Intrinsic Value_3Y_min---1.038--------
Intrinsic Value_5Y_max--0.165--------
Intrinsic Value_5Y_min--0.048--------
Net Profit Margin--0.0440.0440%0.074-41%0.036+20%0.035+25%
Operating Margin----0%-0%0.054-100%0.072-100%
Operating Ratio--0.7410.7410%0.662+12%1.223-39%1.394-47%
Pb Ratio1.200+10%1.0811.0810%1.203-10%1.226-12%1.897-43%
Pe Ratio9.191+10%8.2818.2810%5.625+47%4.352+90%6.826+21%
Peg Ratio--11.78411.7840%1.660+610%11.348+4%9.426+25%
Price Per Share114.150+10%102.850102.8500%99.400+3%89.980+14%97.674+5%
Price To Total Gains Ratio9.137+10%8.2328.2320%5.860+40%4.550+81%5.758+43%
Profit Growth--0.7030.7030%3.389-79%1.522-54%1.954-64%
Quick Ratio--0.3720.3720%0.503-26%0.388-4%0.423-12%
Return On Assets--0.0600.0600%0.106-43%0.050+19%0.053+12%
Return On Equity--0.1310.1310%0.214-39%0.106+23%0.126+4%
Revenue Growth--1.1871.1870%1.346-12%1.102+8%1.209-2%
Total Gains Per Share--12.49412.4940%16.962-26%8.293+51%10.624+18%
Total Gains Per Share Growth--0.7370.7370%3.244-77%1.470-50%1.700-57%
Usd Book Value--18519052.20018519052.2000%16086678.000+15%14384003.760+29%10722101.333+73%
Usd Book Value Change Per Share--0.1540.1540%0.209-26%0.101+52%0.130+18%
Usd Book Value Per Share--1.1701.1700%1.016+15%0.909+29%0.677+73%
Usd Dividend Per Share----0%-0%0.001-100%0.001-100%
Usd Eps--0.1530.1530%0.217-30%0.105+45%0.094+62%
Usd Free Cash Flow----0%-0%-0%-0%
Usd Free Cash Flow Per Share---0.015-0.0150%-0.030+98%0.060-125%0.059-126%
Usd Free Cash Flow To Equity Per Share--0.0080.0080%-0.009+217%0.001+683%0.001+932%
Usd Price Per Share1.404+10%1.2651.2650%1.223+3%1.107+14%1.201+5%
Usd Profit--2417872.5002417872.5000%3440420.700-30%1666394.160+45%1491713.933+62%
Usd Revenue--55481413.20055481413.2000%46757293.800+19%39864838.740+39%35010795.167+58%
Usd Total Gains Per Share--0.1540.1540%0.209-26%0.102+51%0.131+18%
 EOD+2 -3MRQTTM+0 -0YOY+14 -235Y+26 -1410Y+24 -16

3.2. Fundamental Score

Let's check the fundamental score of Mangalam Drugs & Organics Limited based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-159.191
Price to Book Ratio (EOD)Between0-11.200
Net Profit Margin (MRQ)Greater than00.044
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.372
Current Ratio (MRQ)Greater than11.402
Debt to Asset Ratio (MRQ)Less than10.542
Debt to Equity Ratio (MRQ)Less than11.181
Return on Equity (MRQ)Greater than0.150.131
Return on Assets (MRQ)Greater than0.050.060
Total5/10 (50.0%)

3.3. Technical Score

Let's check the technical score of Mangalam Drugs & Organics Limited based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose116.200
Total1/1 (100.0%)



Latest Balance Sheet

Balance Sheet of 2022-03-31. Currency in INR. All numbers in thousands.

Summary
Total Assets3,284,257
Total Liabilities1,778,643
Total Stockholder Equity1,505,614
 As reported
Total Liabilities 1,778,643
Total Stockholder Equity+ 1,505,614
Total Assets = 3,284,257

Assets

Total Assets3,284,257
Total Current Assets1,824,656
Long-term Assets1,824,656
Total Current Assets
Cash And Cash Equivalents 14,349
Net Receivables 464,901
Inventory 1,171,055
Other Current Assets 168,794
Total Current Assets  (as reported)1,824,656
Total Current Assets  (calculated)1,819,099
+/- 5,557
Long-term Assets
Property Plant Equipment 1,267,947
Intangible Assets 138,763
Long-term Assets  (as reported)0
Long-term Assets  (calculated)1,406,710
+/- 1,406,710

Liabilities & Shareholders' Equity

Total Current Liabilities1,301,133
Long-term Liabilities-
Total Stockholder Equity1,505,614
Total Current Liabilities
Short-term Debt 470,962
Total Current Liabilities  (as reported)1,301,133
Total Current Liabilities  (calculated)470,962
+/- 830,171
Long-term Liabilities
Long term Debt Total 342,558
Long term Debt 251,030
Capital Lease Obligations Min Short Term Debt-470,962
Long-term Liabilities  (as reported)0
Long-term Liabilities  (calculated)122,626
+/- 122,626
Total Stockholder Equity
Common Stock158,282
Retained Earnings 1,123,579
Capital Surplus 223,753
Total Stockholder Equity (as reported)1,505,614
Total Stockholder Equity (calculated)1,505,614
+/-0
Other
Cash And Equivalents5,196
Cash and Short Term Investments 19,545
Common Stock Shares Outstanding 15,828
Liabilities and Stockholders Equity 3,284,257



Balance Sheet

Currency in INR. All numbers in thousands.

 Trend2022-03-312021-03-312020-03-312019-03-312018-03-312017-03-312016-03-312015-03-312014-03-31
> Total Assets 
1,254,443
1,698,950
1,597,639
1,895,038
2,267,874
2,113,549
2,306,671
2,641,089
3,284,257
3,284,2572,641,0892,306,6712,113,5492,267,8741,895,0381,597,6391,698,9501,254,443
   > Total Current Assets 
714,150
1,160,369
996,538
957,848
1,228,416
1,050,397
1,191,747
1,339,209
1,824,656
1,824,6561,339,2091,191,7471,050,3971,228,416957,848996,5381,160,369714,150
       Cash And Cash Equivalents 
1,023
6,794
4,953
6,273
4,303
14,334
16,291
837
14,349
14,34983716,29114,3344,3036,2734,9536,7941,023
       Short-term Investments 
1,792
2,402
2,401
2,439
16,561
0
0
0
0
000016,5612,4392,4012,4021,792
       Net Receivables 
297,162
442,738
301,443
368,167
452,077
176,307
399,829
543,122
464,901
464,901543,122399,829176,307452,077368,167301,443442,738297,162
       Inventory 
364,776
573,404
473,406
372,495
601,342
734,532
648,427
585,875
1,171,055
1,171,055585,875648,427734,532601,342372,495473,406573,404364,776
       Other Current Assets 
47,727
132,032
211,022
185,368
170,569
125,136
127,104
204,203
168,794
168,794204,203127,104125,136170,569185,368211,022132,03247,727
   > Long-term Assets 
0
0
0
937,189
1,037,058
1,040,864
1,114,923
0
0
001,114,9231,040,8641,037,058937,189000
       Property Plant Equipment 
533,843
529,479
591,170
925,090
1,012,273
1,032,061
961,736
1,142,137
1,267,947
1,267,9471,142,137961,7361,032,0611,012,273925,090591,170529,479533,843
       Intangible Assets 
0
0
0
472
7,531
4,852
61,359
99,566
138,763
138,76399,56661,3594,8527,531472000
> Total Liabilities 
1,022,214
1,405,309
982,396
1,037,867
1,230,209
1,156,919
1,267,284
1,333,229
1,778,643
1,778,6431,333,2291,267,2841,156,9191,230,2091,037,867982,3961,405,3091,022,214
   > Total Current Liabilities 
614,337
994,319
728,692
777,596
998,447
908,147
1,094,670
1,090,777
1,301,133
1,301,1331,090,7771,094,670908,147998,447777,596728,692994,319614,337
       Short-term Debt 
771,801
779,227
353,757
413,200
507,519
505,120
418,608
511,816
470,962
470,962511,816418,608505,120507,519413,200353,757779,227771,801
       Short Long Term Debt 
771,801
779,227
598,210
662,030
577,827
543,013
458,648
0
0
00458,648543,013577,827662,030598,210779,227771,801
       Accounts payable 
208,673
547,729
206,750
207,755
376,251
324,135
565,934
0
0
00565,934324,135376,251207,755206,750547,729208,673
       Other Current Liabilities 
0
0
638
1,694
10,726
2,878
18,817
0
0
0018,8172,87810,7261,69463800
   > Long-term Liabilities 
0
0
0
308,890
231,763
229,282
172,614
0
0
00172,614229,282231,763308,890000
       Long term Debt Total 
0
0
169,215
168,511
111,464
105,446
49,733
100,660
342,558
342,558100,66049,733105,446111,464168,511169,21500
       Capital Lease Obligations 
0
0
0
0
0
0
19,359
0
0
0019,359000000
       Long-term Liabilities Other 
0
0
0
0
1
-1
5
0
0
005-110000
> Total Stockholder Equity
232,229
293,641
615,243
857,171
1,037,665
956,630
1,039,387
1,307,860
1,505,614
1,505,6141,307,8601,039,387956,6301,037,665857,171615,243293,641232,229
   Common Stock
131,782
131,782
143,782
158,282
158,282
158,282
158,282
158,282
158,282
158,282158,282158,282158,282158,282158,282143,782131,782131,782
   Retained Earnings 
22,444
83,856
471,461
698,889
879,383
798,348
881,105
925,825
1,123,579
1,123,579925,825881,105798,348879,383698,889471,46183,85622,444
   Capital Surplus 
0
0
0
0
0
0
0
223,753
223,753
223,753223,7530000000
   Treasury Stock000000000
   Other Stockholders Equity 
0
0
84,825
0
0
3,801
4,033
0
0
004,0333,8010084,82500



Balance Sheet

Currency in INR. All numbers in thousands.




Cash Flow

Currency in INR. All numbers in thousands.




Income Statement

Currency in INR. All numbers in thousands.


Latest Income Statement (annual, 2022-03-31)

Gross Profit (+$)
totalRevenue4,510,684
Cost of Revenue-3,340,970
Gross Profit1,169,7141,169,714
 
Operating Income (+$)
Gross Profit1,169,714
Operating Expense--
Operating Income388,0541,169,714
 
Operating Expense (+$)
Research Development-
Selling General Administrative659,683
Selling And Marketing Expenses-
Operating Expense-659,683
 
Net Interest Income (+$)
Interest Income71,129
Interest Expense--
Net Interest Income-71,129
 
Pretax Income (+$)
Operating Income388,054
Net Interest Income-
Other Non-Operating Income Expenses-
Income Before Tax (EBT)277,330388,054
EBIT - interestExpense = 0
196,575
196,575
Interest Expense-
Earnings Before Interest and Taxes (ebit)-277,330
Earnings Before Interest and Taxes (ebitda)-
 
After tax Income (+$)
Income Before Tax277,330
Tax Provision-80,755
Net Income From Continuing Ops-196,575
Net Income196,575
Net Income Applicable To Common Shares196,575
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-0
 

Comments

Join the conversation.

Leave a comment

Stay informed with my latest content.

Subscribe to my newsletter and receive an email as soon as I add content to PenkeTrading.com.


By clicking Register, you agree to the General Terms and Conditions.
Penke's Market Notifications
NGU24-NYM.COMM
2 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of NGU24-NYM.COMM.

NGU24-NYM.COMM Daily Candlestick Chart
NGM24-NYM.COMM
2 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of NGM24-NYM.COMM.

NGM24-NYM.COMM Daily Candlestick Chart
NGQ24-NYM.COMM
2 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of NGQ24-NYM.COMM.

NGQ24-NYM.COMM Daily Candlestick Chart
ISKJ.MCX
2 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of ISKJ.MCX.

ISKJ.MCX Daily Candlestick Chart
CHKZ.MCX
2 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of CHKZ.MCX.

CHKZ.MCX Daily Candlestick Chart
VSYD.MCX
2 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of VSYD.MCX.

VSYD.MCX Daily Candlestick Chart
VRSB.MCX
2 hours ago

I found you a Golden Cross on the daily chart of VRSB.MCX.

VRSB.MCX Daily Candlestick Chart
TBRU.MCX
2 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of TBRU.MCX.

TBRU.MCX Daily Candlestick Chart
SNGSP.MCX
2 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of SNGSP.MCX.

SNGSP.MCX Daily Candlestick Chart
RBCM.MCX
2 hours ago

I found you a Golden Cross on the daily chart of RBCM.MCX.

RBCM.MCX Daily Candlestick Chart
OKEY.MCX
2 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of OKEY.MCX.

OKEY.MCX Daily Candlestick Chart
MTLR.MCX
3 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of MTLR.MCX.

MTLR.MCX Daily Candlestick Chart
MRKZ.MCX
3 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of MRKZ.MCX.

MRKZ.MCX Daily Candlestick Chart
KRKN.MCX
3 hours ago

I found you a STOCH Bearish Reversal Divergence on the daily chart of KRKN.MCX.

KRKN.MCX Daily Candlestick Chart
JNOS.MCX
3 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of JNOS.MCX.

JNOS.MCX Daily Candlestick Chart
BLNG.MCX
3 hours ago

I found you a Golden Cross on the daily chart of BLNG.MCX.

BLNG.MCX Daily Candlestick Chart
ASSB.MCX
3 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of ASSB.MCX.

ASSB.MCX Daily Candlestick Chart
CSYZ.MU
3 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of CSYZ.MU.

CSYZ.MU Daily Candlestick Chart
MOH.MU
3 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of MOH.MU.

MOH.MU Daily Candlestick Chart
TBK.V
3 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of TBK.V.

TBK.V Daily Candlestick Chart
UMDK.F
3 hours ago

I found you a STOCH Bullish Hidden Divergence on the daily chart of UMDK.F.

UMDK.F Daily Candlestick Chart
RY4C.BE
3 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of RY4C.BE.

RY4C.BE Daily Candlestick Chart
PLY.BE
3 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of PLY.BE.

PLY.BE Daily Candlestick Chart
PDL.LSE
3 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of PDL.LSE.

PDL.LSE Daily Candlestick Chart
27F0.MU
3 hours ago

I found you a STOCH Bearish Reversal Divergence on the daily chart of 27F0.MU.

27F0.MU Daily Candlestick Chart